CD8A and cancer: As shown in various cancer types, both cancer cells and M2 TAM express elevated levels of programmed T cell death ligand 1 (PD-L1), which is well known as an immune checkpoint for cytotoxic CD8+ T cells, inhibiting their ability to kill cancer cells [154,158,159,160].